Dr. David Eugene Hrncir, MD

Dr. Hrncir practices at The Orthopaedic Surgery Center of San Antonio in San Antonio, Texas.

Dr. Hrncir's NPI, 1023080124, was assigned on February 2, 2006. Dr. Hrncir graduated from UT Southwestern Medical Center in 1980. Dr. Hrncir holds Texas license F9592.

Dr. Hrncir's primary practice is The Orthopaedic Surgery Center of San Antonio, at 400 Concord Plaza Drive Suite 200, San Antonio, TX 78216. The practice phone is (210) 253-2660.

Dr. Hrncir's primary practice is The Orthopaedic Surgery Center of San Antonio in San Antonio, Texas. The medical group on file is University Medicine Associates. Dmand AI also links Dr. Hrncir to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hrncir practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Hrncir's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Hrncir is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Hrncir is licensed in Texas.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Hrncir treats.

CMS data shows 2,369 Medicare services from Dr. Hrncir across 7 procedure codes in 2024, for 108 Medicare patients. Medicare paid $31,824 for them. Every service was in an office.

CMS counts 108 Medicare patients who saw Dr. Hrncir in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hrncir's median patient age at 54, with 65% women.

In 2024, Dr. Hrncir wrote 321 Medicare Part D claims for 86 patients. 73% of them were for generic drugs. CMS names the drug for 232 of them, across 11 drugs with 11 or more claims each, at $17,655 in total drug cost. In 2023, CMS named 291 claims across 12 drugs.

Dr. Hrncir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Hrncir in 2023. 2023 was the busiest year, with 2. The most frequent topics are Vaccination, Influenza, Human and Military Health Services. Dr. Hrncir's most frequent co-authors are Thomas Marshall Beachkofsky, MD, Limone Collins, MD and Leslie T. Cooper, MD.

CMS Open Payments shows 348 general payments to Dr. Hrncir from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Sanofi and Genzyme US Companies paid the most, $2,058.

Dr. Hrncir graduated from UT Southwestern Medical Center in 1980.

Dr. Hrncir is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.